Published in Clin Microbiol Infect on April 01, 2014
Emerging pan-resistance in Trichosporon species: a case report. BMC Infect Dis (2016) 1.45
Molecular and nonmolecular diagnostic methods for invasive fungal infections. Clin Microbiol Rev (2014) 0.99
Malassezia yeasts: how many species infect humans and animals? PLoS Pathog (2014) 0.94
Malassezia infections in humans and animals: pathophysiology, detection, and treatment. PLoS Pathog (2015) 0.89
Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital. Antimicrob Agents Chemother (2015) 0.86
Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study. Eur J Clin Microbiol Infect Dis (2014) 0.85
Epidemiology and Outcome of Trichosporon Fungemia: A Review of 185 Reported Cases From 1975 to 2014. Open Forum Infect Dis (2015) 0.84
The production of reactive oxygen species is a universal action mechanism of Amphotericin B against pathogenic yeasts and contributes to the fungicidal effect of this drug. Antimicrob Agents Chemother (2014) 0.84
Pseudozyma aphidis fungemia after abdominal surgery: First adult case. Med Mycol Case Rep (2015) 0.84
Fungi on the skin: dermatophytes and Malassezia. Cold Spring Harb Perspect Med (2014) 0.82
Two Case Presentations Infected by Trichosporon asahii and Treated with Voriconazole Successfully. Case Rep Infect Dis (2015) 0.82
On and Under the Skin: Emerging Basidiomycetous Yeast Infections Caused by Trichosporon Species. PLoS Pathog (2015) 0.80
Candida haemulonii species complex: an emerging species in India and its genetic diversity assessed with multilocus sequence and amplified fragment-length polymorphism analyses. Emerg Microbes Infect (2016) 0.80
Invasive Trichosporon Infection: a Systematic Review on a Re-emerging Fungal Pathogen. Front Microbiol (2016) 0.79
Pseudozyma aphidis fungaemia with invasive fungal pneumonia in a patient with acute myeloid leukaemia: case report and literature review. Mycoses (2015) 0.79
Rhodotorula mucilaginosa associacted meningitis: A subacute entity with high mortality. Case report and review. Med Mycol Case Rep (2014) 0.78
In Vitro Interactions between Non-Steroidal Anti-Inflammatory Drugs and Antifungal Agents against Planktonic and Biofilm Forms of Trichosporon asahii. PLoS One (2016) 0.77
Misidentification of a Rare Species, Cryptococcus laurentii, by Commonly Used Commercial Biochemical Methods and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Systems: Challenges for Clinical Mycology Laboratories. J Clin Microbiol (2015) 0.77
In vitro amphotericin B susceptibility of Malassezia pachydermatis determined by the CLSI broth microdilution method and Etest using lipid-enriched media. Antimicrob Agents Chemother (2014) 0.77
Antifungal Activity and Action Mechanism of Histatin 5-Halocidin Hybrid Peptides against Candida ssp. PLoS One (2016) 0.76
Development of a loop-mediated isothermal amplification assay for rapid detection of Trichosporon asahii in experimental and clinical samples. Biomed Res Int (2015) 0.76
Experimental therapy with azoles against Candida guilliermondii. Antimicrob Agents Chemother (2014) 0.76
Kodameae ohmeri - An Emerging Yeast: Two Cases and Literature Review. J Clin Diagn Res (2015) 0.75
Retrospective Analysis on the Use of Amphotericin B Lipid Complex in Neutropenic Cancer Patients with Suspected Fungal Infections in Lebanon, a Single Center Experience and Review of International Guidelines. Front Med (Lausanne) (2016) 0.75
The Cell Biology of the Trichosporon-Host Interaction. Front Cell Infect Microbiol (2017) 0.75
Use of combination therapy to successfully treat breakthrough Trichosporon asahii infection in an acute leukemia patient receiving voriconazole. Med Mycol Case Rep (2014) 0.75
Trichosporon faecale invasive infection in a patient with severe aplastic anemia: Efficacy of voriconazole and liposomal amphotericin B before neutrophil recovery. Med Mycol Case Rep (2015) 0.75
First case of invasive Magnusiomyces capitatus infection in Slovakia. Med Mycol Case Rep (2017) 0.75
Granulocyte transfusions in the management of invasive fungal infections. Br J Haematol (2017) 0.75
Antifungal Susceptibility Testing of Ascomycetous Yeasts Isolated from Animals. Antimicrob Agents Chemother (2016) 0.75
Saprochaete clavata invasive infection in a patient with severe aplastic anemia: Efficacy of voriconazole and liposomal amphotericin B with adjuvant granulocyte transfusions before neutrophil recovery following allogeneic bone marrow transplantation. Med Mycol Case Rep (2016) 0.75
Successful management of gastropulmonary fistula due to invasive fungal infection after chemotherapy and autologous stem cell transplantation: a case report. Acta Med Litu (2016) 0.75
Rhodotorula keratitis: a rarely encountered ocular pathogen. Case Rep Ophthalmol (2014) 0.75
In Vitro Antifungal Activity of Sertraline and Synergistic Effects in Combination with Antifungal Drugs against Planktonic Forms and Biofilms of Clinical Trichosporon asahii Isolates. PLoS One (2016) 0.75
Diagnosis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-2). Turk J Haematol (2014) 0.75
Efficacy of Posaconazole in a Murine Model of Systemic Infection by Saprochaete capitata. Antimicrob Agents Chemother (2015) 0.75
Primary fungal prophylaxis in acute leukemia patients with different risk factors: retrospective analysis from the CAESAR study. Int J Hematol (2017) 0.75
Cryptococcosis in HIV-negative Patients with Renal Dialysis: A Retrospective Analysis of Pooled Cases. Mycopathologia (2017) 0.75
Cross-reacting Ustilago maydis Causing False-Positive Cryptococcal Antigen Tests. J Clin Microbiol (2017) 0.75
Nebulized Liposomal Amphotericin B for Treatment of Pulmonary Infection Caused by Hormographiella aspergillata: Case Report and Literature Review. Mycopathologia (2017) 0.75
In Vitro Interactions of Echinocandins with Triazoles Against Multidrug-Resistant Candida auris. Antimicrob Agents Chemother (2017) 0.75
Cutaneous lesions due to Trichosporon jirovecii in a tortoise (Testudo hermanni). Med Mycol Case Rep (2017) 0.75
Lipid Metabolic Versatility in Malassezia spp. Yeasts Studied through Metabolic Modeling. Front Microbiol (2017) 0.75
Disseminated Cutaneous Trichosporonosis in an Adult Bone Marrow Transplant Patient. Indian Dermatol Online J (2017) 0.75
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis (2001) 12.73
A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci U S A (2004) 6.21
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect (2012) 4.56
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest (2007) 3.58
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update. Bone Marrow Transplant (2010) 3.46
Biodiversity and systematics of basidiomycetous yeasts as determined by large-subunit rDNA D1/D2 domain sequence analysis. Int J Syst Evol Microbiol (2000) 3.14
Mediastinitis due to multiple resistant Corynebacterium xerosis. Clin Infect Dis (1993) 3.14
OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1993) 3.09
Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry. Arthritis Rheum (2009) 2.92
General primer-mediated PCR for detection of Aspergillus species. J Clin Microbiol (1994) 2.81
Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) (1996) 2.72
Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3. Nat Med (2000) 2.70
Rapid, polymerase chain reaction-based identification assays for Candida species. J Clin Microbiol (1993) 2.70
Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect (2010) 2.63
Colorimetric assay for antifungal susceptibility testing of Aspergillus species. J Clin Microbiol (2001) 2.53
Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol (1997) 2.53
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect (2014) 2.47
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect (2011) 2.38
Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection. Antimicrob Agents Chemother (2006) 2.31
Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol (2007) 2.29
Escherichia coli native valve endocarditis. Clin Microbiol Infect (2006) 2.28
Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? Antimicrob Agents Chemother (2013) 2.14
Aspergillus fumigatus pneumonia in neutropenic patients during therapy with fluconazole for infection due to Candida species. Clin Infect Dis (1993) 2.13
Tuberculosis in HIV-infected patients: a comprehensive review. Clin Microbiol Infect (2004) 2.13
[Postanginal sepsis caused by Fusobacterium necrophorum: Lemierre syndrome]. Ned Tijdschr Geneeskd (1993) 2.11
Emergence of Candida krusei infections after therapy of oropharyngeal candidiasis with fluconazole. Eur J Clin Microbiol Infect Dis (1991) 2.08
A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007). Clin Infect Dis (2012) 2.07
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis (2004) 2.06
Six monophyletic lineages identified within Cryptococcus neoformans and Cryptococcus gattii by multi-locus sequence typing. Fungal Genet Biol (2007) 2.04
Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy (2013) 2.03
Invasive aspergillosis caused by Aspergillus ustus: case report and review. J Clin Microbiol (1999) 2.02
Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients. J Clin Microbiol (1995) 1.96
Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies. J Clin Microbiol (1995) 1.89
Synchronization of Plasmodium falciparum gametocytes using an automated suspension culture system. Parasitology (1986) 1.78
Comparison of NCCLS and 3-(4,5-dimethyl-2-Thiazyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development of a new simplified method. J Clin Microbiol (2000) 1.76
Haemophilus endocarditis: report of 42 cases in adults and review. Haemophilus Endocarditis Study Group. Clin Infect Dis (1997) 1.75
Comparative study of seven commercial yeast identification systems. J Clin Pathol (1999) 1.74
Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants. J Immunol (1994) 1.72
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect (2014) 1.70
Primary structure and localization of a conserved immunogenic Plasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate life cycle. Mol Biochem Parasitol (1991) 1.70
Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients. Intensive Care Med (2014) 1.68
Analysis of growth characteristics of filamentous fungi in different nutrient media. J Clin Microbiol (2001) 1.68
Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions. BMJ (1993) 1.65
Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans. J Immunol (1999) 1.64
Multidrug-resistant endemic clonal strain of Candida auris in India. Eur J Clin Microbiol Infect Dis (2013) 1.61
In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans. Antimicrob Agents Chemother (2000) 1.61
Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals. Eur J Clin Microbiol Infect Dis (1996) 1.60
Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry. Ann Rheum Dis (2010) 1.59
A primer on cytokines: sources, receptors, effects, and inducers. Clin Microbiol Rev (1997) 1.57
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin Microbiol Infect (2012) 1.55
Characterization of verocytotoxin-producing Escherichia coli O157 isolates from patients with haemolytic uraemic syndrome in Western Europe. Epidemiol Infect (1995) 1.54
Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units. J Clin Microbiol (2001) 1.52
Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii group I), C. duobushaemulonii sp. nov. (C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts. J Clin Microbiol (2012) 1.51
Streptococcus pneumoniae endocarditis in adults. A multicenter study in France in the era of penicillin resistance (1991-1998). The Pneumococcal Endocarditis Study Group. Medicine (Baltimore) (2000) 1.50
Typing of Aspergillus species and Aspergillus fumigatus isolates by interrepeat polymerase chain reaction. J Clin Microbiol (1993) 1.49
Schizophyllum commune as an emerging fungal pathogen: a review and report of two cases. Mycoses (2012) 1.48
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. Clin Microbiol Infect (2012) 1.48
Fas-FasL interactions modulate host defense against systemic Candida albicans infection. J Infect Dis (1999) 1.47
The role of Malassezia species in the ecology of human skin and as pathogens. Med Mycol (1998) 1.47
[Clinical research in orthopaedics--creation of a clinical trial unit in orthopaedics/trauma surgery]. Z Orthop Unfall (2010) 1.45
Genotypic characterization of sequential Candida albicans isolates from fluconazole-treated neutropenic patients. J Infect Dis (1994) 1.43
Cryptococcus neoformans shows a remarkable genotypic diversity in Brazil. J Clin Microbiol (2004) 1.41
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect (2012) 1.41
Microcoding: the second step in DNA barcoding. Philos Trans R Soc Lond B Biol Sci (2005) 1.41
Molecular sequence analyses of the intergenic spacer (IGS) associated with rDNA of the two varieties of the pathogenic yeast, Cryptococcus neoformans. Syst Appl Microbiol (2000) 1.41
Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis. Antimicrob Agents Chemother (2006) 1.40
[62-year-old patient with chronic lymphatic leukaemia and persistent fever in chemotherapy induced bone marrow aplasia. Angioinvasive aspergillosis]. Dtsch Med Wochenschr (2011) 1.39
Prevalence of vancomycin-resistant enterococci in Europe. Eur J Clin Microbiol Infect Dis (2000) 1.39
[A very serious course of psittacosis in pregnancy]. Ned Tijdschr Geneeskd (1998) 1.39
[Management of systemic candidiasis]. Presse Med (1999) 1.39
[Invasive aspergillosis: epidemiology, diagnosis and therapy]. Ned Tijdschr Geneeskd (1994) 1.39
Validation of a modified algorithm for the identification of yeast isolates using matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS). Eur J Clin Microbiol Infect Dis (2011) 1.38
[Systemic granulomatosis of infectious origin]. Rev Med Interne (2007) 1.38
Clinical evaluation and reproducibility of the Pastorex Aspergillus antigen latex agglutination test for diagnosing invasive aspergillosis. J Clin Pathol (1995) 1.36
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. Clin Microbiol Infect (2014) 1.36